» Articles » PMID: 18237025

Enzyme Inhibition Activities of the Extracts from Rhizomes of Gloriosa Superba Linn (Colchicaceae)

Overview
Specialty Biochemistry
Date 2008 Feb 2
PMID 18237025
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

An alcoholic extract obtained from the rhizomes of Gloriosa superba Linn (Colchicaceae) was screened for enzyme inhibition activities. The crude extract and its subsequent fractions including chloroform, ethyl acetate, n-butanol and aqueous were screened against lipoxygenase, actylcholinesterase, butyrylcholinesterase and urease. An outstanding inhibition on lipoxygenase was observed. The highest enzyme inhibition potency was expressed by the chloroform fraction (90%) among the tested fractions on lipoxygenase. Overall 67-90% inhibition was found for lipoxygenase, 46-69% for acetylcholinesterase and 10-33% for butyrylcholinesterase, while urease was not inhibited.

Citing Articles

Lipoxygenase inhibitory synthetic derivatives of methyl gallate regulate gene expressions of COX-2 and cytokines to reduce animal model arthritis.

Sharanya C, Abhithaj J, Arun K, Eeda K, Bhat V, Variyar E Sci Rep. 2023; 13(1):10644.

PMID: 37391468 PMC: 10313808. DOI: 10.1038/s41598-023-37613-z.


Mineral Profile, Antioxidant, Anti-Inflammatory, Antibacterial, Anti-Urease and Anti-α-Amylase Activities of the Unripe Fruit Extracts of .

Benmohamed M, Guenane H, Messaoudi M, Zahnit W, Egbuna C, Sharifi-Rad M Molecules. 2023; 28(1).

PMID: 36615545 PMC: 9824078. DOI: 10.3390/molecules28010349.


Antiproliferative Potential of Gloriosine: A Lead for Anticancer Drug Development.

Goel B, Dey B, Chatterjee E, Tripathi N, Bhardwaj N, Kumar S ACS Omega. 2022; 7(33):28994-29001.

PMID: 36033689 PMC: 9404168. DOI: 10.1021/acsomega.2c02688.


Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase.

Obaid R, Naeem N, Mughal E, Al-Rooqi M, Sadiq A, Jassas R RSC Adv. 2022; 12(31):19764-19855.

PMID: 35919585 PMC: 9275557. DOI: 10.1039/d2ra03081k.


Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations.

Vikram E, Ilavarasan R, Kamaraj R J Ayurveda Integr Med. 2022; 13(2):100545.

PMID: 35661925 PMC: 9163510. DOI: 10.1016/j.jaim.2022.100545.